As we have reported in past issues, our firm is currently involved in litigation with Merck involving the drug Fosamax. The drug has been linked primarily to two types of injuries. One is Osteonecrosis of the Jaw (ONJ) and the other injury is Femur Fracture. ONJ is a debilitating and disfiguring condition which literally means “jaw death.” You may recall our reporting on the Boles case in the Fosamax MDL in New York which involved ONJ and took place last year resulting in a hung jury. The case was recently re-tried, resulting in an $8 million verdict for the Plaintiff. Since that time, Judge Keenan has entered an order giving the Plaintiff the option of taking a reduced verdict of $1.5 million or re-trying the damages portion of the case. There are three more Fosamax ONJ cases scheduled to go to trial in the MDL over the next eight months. Lawyers in our firm’s Mass Torts Section have stayed busy on these cases and they are currently preparing to try a Fosamax ONJ case in January in Alabama.
The second type of injury we are investigating is subtrochanteric femur fractures. These fractures are occurring with little or no trauma to the femur. They are also referred to as “low-energy” femur fractures. On October 13, 2010 the FDA sent out an advisory to patients and health care professionals warning them of the risk of femoral fractures linked to oral bisphosphonates, including Fosamax. There is consolidated litigation in New Jersey regarding Fosamax claims, some of which involve femur fractures. There are cases in New Jersey scheduled to go to trial this year as well. If you want additional information on the Fosamax Litigation please contact Chad Cook in our Mass Torts Section at 800-898-2034 or by email at Chad.Cook@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.